PredictImmune raised €11M in a Series B round in Jul 2019. The company is based in Cambridge, UK. Investors in the round: Parkwalk Advisors, University of Cambridge Enterprise. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
